{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:59:42Z","timestamp":1787497182289,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015731","name":"Bayer Yakuhin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.xkme.2020.09.003","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T19:39:36Z","timestamp":1602963576000},"page":"742-752.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan"],"prefix":"10.1016","volume":"2","author":[{"given":"Eiichiro","family":"Kanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4402-0209","authenticated-orcid":false,"given":"Suguru","family":"Okami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xkme.2020.09.003_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1313341","article-title":"An integrated view of potassium homeostasis","volume":"373","author":"Gumz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.xkme.2020.09.003_bib2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2215\/CJN.08580813","article-title":"Regulation of potassium homeostasis","volume":"10","author":"Palmer","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2020.09.003_bib3","first-page":"43","article-title":"Potassium-binding agents for the clinical management of hyperkalemia","volume":"41","author":"Chaitman","year":"2016","journal-title":"P.T"},{"issue":"12","key":"10.1016\/j.xkme.2020.09.003_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.amjmed.2015.05.040","article-title":"Management of hyperkalemia: an update for the internist","volume":"128","author":"Kovesdy","year":"2015","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.xkme.2020.09.003_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5114\/aoms.2014.42577","article-title":"Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes","volume":"10","author":"Khanagavi","year":"2014","journal-title":"Arch Med Sci"},{"issue":"6","key":"10.1016\/j.xkme.2020.09.003_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","article-title":"Managing hyperkalemia caused by inhibitors of the renin\u2013angiotensin\u2013aldosterone system","volume":"351","author":"Palmer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.xkme.2020.09.003_bib7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ekir.2019.05.018","article-title":"Hyperkalemia in real-world patients under continuous medical care in Japan","volume":"4","author":"Kashihara","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.xkme.2020.09.003_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/0885066605278969","article-title":"Hyperkalemia: a review","volume":"20","author":"Evans","year":"2005","journal-title":"J\u00a0Intensive Care Med"},{"issue":"suppl A","key":"10.1016\/j.xkme.2020.09.003_bib9","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1093\/eurheartj\/suy028","article-title":"Hyperkalemia: aetiology, epidemiology, and clinical significance","volume":"21","author":"Tromp","year":"2019","journal-title":"Eur Heart J Suppl"},{"issue":"1","key":"10.1016\/j.xkme.2020.09.003_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.01730215","article-title":"Association between serum potassium and outcomes in patients with reduced kidney function","volume":"11","author":"Luo","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2020.09.003_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000479802","article-title":"Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes","volume":"46","author":"Collins","year":"2017","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2020.09.003_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ehf2.12402","article-title":"Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21334 patients in the UK","volume":"6","author":"Linde","year":"2019","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.xkme.2020.09.003_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12882-018-1007-1","article-title":"Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink","volume":"19","author":"Furuland","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.xkme.2020.09.003_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026465","article-title":"Healthcare resource utilization and cost associated with elevated potassium levels: a Danish population-based cohort study","volume":"9","author":"Kim","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.xkme.2020.09.003_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ekir.2017.11.003","article-title":"The cost of hyperkalemia in the United States","volume":"3","author":"Betts","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.xkme.2020.09.003_bib16","first-page":"202","article-title":"The clinical and economic burden of hyperkalemia on Medicare and commercial payers","volume":"10","author":"Fitch","year":"2017","journal-title":"Am Health Drug Benefits"},{"issue":"6","key":"10.1016\/j.xkme.2020.09.003_bib17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/03007995.2018.1433141","article-title":"The prevalence of hyperkalemia in the United States","volume":"34","author":"Betts","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"10.1016\/j.xkme.2020.09.003_bib18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrneph.2014.168","article-title":"Management of hyperkalemia in chronic kidney disease","volume":"10","author":"Kovesdy","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.xkme.2020.09.003_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1258\/1355819042250249","article-title":"Multiple regression of cost data: use of generalised linear models","volume":"9","author":"Barber","year":"2004","journal-title":"J\u00a0Health Serv Res Policy"},{"key":"10.1016\/j.xkme.2020.09.003_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2753.2006.00610.x","article-title":"A\u00a0comparison of multivariate regression models to analyse cost data","volume":"12","author":"Dodd","year":"2006","journal-title":"J\u00a0Eval Clin Pract"},{"key":"10.1016\/j.xkme.2020.09.003_bib22","first-page":"835","article-title":"How much does hyperkalemia lengthen inpatient stays? About methodological issues in analyzing time-dependent events","volume":"210","author":"Chazard","year":"2015","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.xkme.2020.09.003_bib23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijcard.2016.11.050","article-title":"Review of early hospitalization after percutaneous coronary intervention","volume":"227","author":"Kwok","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.xkme.2020.09.003_bib24","unstructured":"US Renal Data System. Chapter 4: hospitalization. In: USRDS 2017 Annual Data Report: epidemiology of kidney disease in the United States. Accessed August 28, 2019. https:\/\/www.usrds.org\/2017\/download\/v2_c04_Hospitalization_17.pdf"},{"key":"10.1016\/j.xkme.2020.09.003_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1681\/ASN.2018080858","article-title":"Prior hospitalization burden and the relatedness of 30-day readmissions in patients receiving hemodialysis","volume":"30","author":"Lin","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2020.09.003_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12882-019-1228-y","article-title":"The value of maintaining normokalemia and enabling RAASi therapy in chronic kidney disease","volume":"20","author":"Evans","year":"2019","journal-title":"BMC Nephrol"},{"issue":"suppl A","key":"10.1016\/j.xkme.2020.09.003_bib27","doi-asserted-by":"crossref","first-page":"A28","DOI":"10.1093\/eurheartj\/suy035","article-title":"Pharmacology of new treatments for hyperkalemia: patiromer and sodium zirconium cyclosiliate","volume":"21","author":"Rosano","year":"2019","journal-title":"Eur Heart J Suppl"},{"issue":"4","key":"10.1016\/j.xkme.2020.09.003_bib28","first-page":"279","article-title":"DRG\/PPS and DPC\/PDPS as prospective payment system","volume":"55","author":"Ishii","year":"2012","journal-title":"JMAJ"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059520302120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059520302120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:22:38Z","timestamp":1762910558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059520302120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2590059520302120"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2020.09.003","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}